Could cannabis help fight diabetes? a study investigates

NCT ID NCT04114903

Completed Knowledge-focused Sponsor: University of Colorado, Boulder Source: ClinicalTrials.gov ↗

First seen Aug 06, 2026 · Last updated Aug 07, 2026 · Updated 1 time

Summary

This study explores whether compounds in cannabis, like THC and CBD, can reduce inflammation and improve how the body responds to insulin. Researchers will measure blood markers of inflammation and insulin sensitivity in people across the weight spectrum, both after a single use and after four weeks of regular use. The goal is to understand if cannabis might play a role in metabolic health.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Cannabis flower with varying levels of THC and CBD
What this could lead to: If cannabis compounds reduce inflammation and improve insulin sensitivity, this could point toward new approaches for managing type 2 diabetes and obesity.
What could go wrong: This is an observational study, so it cannot prove cause and effect. Results may vary by individual, and cannabis use carries its own health risks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANNABIS USE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cannabis dependence diabetes mellitus Insulin Resistance Obesity obesity disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANNABIS USE INSULIN SENSITIVITY OBESITY TYPE 2 DIABETES

Contacts and locations

Locations

Center for Innovation and Creativity

Boulder, Colorado, 80301, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.